Femalegra

Femalegra is designed to treat female sexual arousal disorder (FSAD) and hypoactive sexual desire disorder (HSDD).

Femalegra usually refers to a class of medications known as PDE5 inhibitors.

How PDE5 Inhibitors affect the female body

In men, the effect is mechanical (an erection). In women, the physiological response is more subtle but follows the same principle of hemodynamics:

Increased Pelvic Blood Flow: The primary effect is engorgement of the clitoral and labial tissues.

Enhanced Lubrication: Increased blood flow to the vaginal walls can stimulate the production of natural moisture.

Heightened Sensitivity: Because the nerve endings in the pelvic region are more heavily perfused with blood, some women report increased sensitivity to touch.